Industry

DUBLIN–(BUSINESS WIRE)–The “Corneal Pachymetry Market Analysis, by Type, by Application, by End User, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The corneal pachymetry market size is estimated to be USD 345.27 million in 2021 and is expected to witness a CAGR of 4.76% during the forecast period … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Reefer Container for Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Application Type and Container Size” report has been added to ResearchAndMarkets.com’s offering. The reefer container for pharmaceutical market is expected to reach US$ 6,391.8 million by 2028 from US$ 2,846.7 million in 2021. It is estimated to grow … [Read more…]

SINGAPORE–(BUSINESS WIRE)–#BLA–Prestige Biopharma Limited, a Singapore-based biopharmaceutical company, has submitted a request to the U.S. Food and Drug Administration (FDA) for a pre-submission meeting to discuss the company’s planned Biologics License Application (BLA) for its Herceptin Biosimilar, HD201(Tuznue®). The Biosimilar Biological Product Development (BPD) Type 4 Meeting is to discuss the format and content of … [Read more…]

– 33 Korean companies exhibit and sell their products in Kuala Lumpur, Malaysia from October 17 to October 19 CHEONGJU, South Korea & KUALA LUMPUR, Malaysia–(BUSINESS WIRE)–#2022ChungbukBestProductPromotion–Chungcheongbuk-do has started to secure export channels for promising exporters in North Chungcheong Province to the Malaysian market. The 2022 CHUNGBUK BEST PRODUCT PROMOTION will be held by Chungcheongbuk-do … [Read more…]

BELLEVUE, Wash.–(BUSINESS WIRE)–$NVOS #AAPI–Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the pricing of its public offering of an aggregate of 4,000,000 units at a public offering price of $0.50 per unit. Each unit consists of (i) one share of common stock (or one pre-funded warrant in lieu thereof), (ii) one … [Read more…]

BEIJING & BURLINGTON, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced that data from its gene therapy research agreement with the Horae Gene Therapy Center, at the UMass Chan Medical School, was … [Read more…]

2022 C3 Summit Program Concludes October 20 in Princeton, New Jersey NEW YORK–(BUSINESS WIRE)–TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced a final call for registration for the 2022 Conversations on Clinical Content (C3) summit. The event is the … [Read more…]

PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS #Fortune500–The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.325 per share for the fourth quarter of 2022. The dividend will be paid on Thursday, December 1, 2022, to all holders of record of the Company’s common stock as of the close of business on Tuesday, November 1, … [Read more…]

Collaboration strengthens patient access to PALFORZIA through Allergy Partners’ national network of specialty practices Children and teenagers aged 4 through 17 years with a confirmed diagnosis of peanut allergy to benefit from direct access to high-quality treatment and improved specialty care Important step forward for Allergy Partners, less than one year after its strategic partnership … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–ixlayer, the leading health testing platform today announced that it has joined Moving Health Home (MHH), a coalition of stakeholders working to change federal and state policy to enable the home to be a clinical site of care. ixlayer joins 25 MHH member companies, including Amazon Care, Amwell, Hackensack Meridian Health, Intermountain Healthcare, … [Read more…]